Lag-3 antibody pharmaceutical composition and use thereof
AssigneesJiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.
InventorsTingting WU, Hao LI, Xun LIU, Yayuan FU
Life of this patent
Estimating the term…
Abstract
Disclosed are a lymphocyte-activation gene 3 (LAG-3) antibody pharmaceutical composition and the use thereof. The pharmaceutical composition comprises a LAG-3 antibody or an antigen-binding fragment thereof in an acetate buffer or in a histidine salt buffer. The pharmaceutical composition may also comprise saccharide, non-ionic surfactant and other excipients.
Claims34
A pharmaceutical composition comprising a LAG-3 antibody or an antigen-binding fragment thereof, and a buffer, wherein the buffer is selected from the group consisting of acetate buffer, histidine buffer, citrate buffer, succinate buffer and Tris buffer.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.